[1]
Shill, D.K. et al. 2023. Design, Optimization and In vitro Evaluation of Mesalazine 400 mg Delayed Release Tablet for Colon Specific Delivery. Dhaka University Journal of Pharmaceutical Sciences. 22, 2 (Dec. 2023), 189–201. DOI:https://doi.org/10.3329/dujps.v22i2.69325.